| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 4.7e-05 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.096 | 0.1 |